BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10809954)

  • 1. Lysosomal cathepsin B plays an important role in antigen processing, while cathepsin D is involved in degradation of the invariant chain inovalbumin-immunized mice.
    Zhang T; Maekawa Y; Hanba J; Dainichi T; Nashed BF; Hisaeda H; Sakai T; Asao T; Himeno K; Good RA; Katunuma N
    Immunology; 2000 May; 100(1):13-20. PubMed ID: 10809954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pepstatin A-sensitive aspartic proteases in lysosome are involved in degradation of the invariant chain and antigen-processing in antigen presenting cells of mice infected with Leishmania major.
    Zhang T; Maekawa Y; Yasutomo K; Ishikawa H; Fawzy Nashed B; Dainichi T; Hisaeda H; Sakai T; Kasai M; Mizuochi T; Asao T; Katunuma N; Himeno K
    Biochem Biophys Res Commun; 2000 Sep; 276(2):693-701. PubMed ID: 11027533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both cathepsin B and cathepsin D are necessary for processing of ovalbumin as well as for degradation of class II MHC invariant chain.
    Mizuochi T; Yee ST; Kasai M; Kakiuchi T; Muno D; Kominami E
    Immunol Lett; 1994 Dec; 43(3):189-93. PubMed ID: 7721331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switch of CD4+ T cell differentiation from Th2 to Th1 by treatment with cathepsin B inhibitor in experimental leishmaniasis.
    Maekawa Y; Himeno K; Ishikawa H; Hisaeda H; Sakai T; Dainichi T; Asao T; Good RA; Katunuma N
    J Immunol; 1998 Sep; 161(5):2120-7. PubMed ID: 9725203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel physiological functions of cathepsins B and L on antigen processing and osteoclastic bone resorption.
    Katunuma N; Matsunaga Y; Matsui A; Kakegawa H; Endo K; Inubushi T; Saibara T; Ohba Y; Kakiuchi T
    Adv Enzyme Regul; 1998; 38():235-51. PubMed ID: 9762356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice.
    Maehr R; Hang HC; Mintern JD; Kim YM; Cuvillier A; Nishimura M; Yamada K; Shirahama-Noda K; Hara-Nishimura I; Ploegh HL
    J Immunol; 2005 Jun; 174(11):7066-74. PubMed ID: 15905550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin S activity regulates antigen presentation and immunity.
    Riese RJ; Mitchell RN; Villadangos JA; Shi GP; Palmer JT; Karp ER; De Sanctis GT; Ploegh HL; Chapman HA
    J Clin Invest; 1998 Jun; 101(11):2351-63. PubMed ID: 9616206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cathepsin L regulates CD4+ T cell selection independently of its effect on invariant chain: a role in the generation of positively selecting peptide ligands.
    Honey K; Nakagawa T; Peters C; Rudensky A
    J Exp Med; 2002 May; 195(10):1349-58. PubMed ID: 12021314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Destructive potential of the aspartyl protease cathepsin D in MHC class II-restricted antigen processing.
    Moss CX; Villadangos JA; Watts C
    Eur J Immunol; 2005 Dec; 35(12):3442-51. PubMed ID: 16259009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of antigen-presenting cells and interleukin-12 in the priming of antigen-specific CD4+ T cells by immune stimulating complexes.
    Robson NC; Beacock-Sharp H; Donachie AM; Mowat AM
    Immunology; 2003 Sep; 110(1):95-104. PubMed ID: 12941146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cathepsin L is crucial for a Th1-type immune response during Leishmania major infection.
    Onishi K; Li Y; Ishii K; Hisaeda H; Tang L; Duan X; Dainichi T; Maekawa Y; Katunuma N; Himeno K
    Microbes Infect; 2004 Apr; 6(5):468-74. PubMed ID: 15109961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limiting dilution analysis of CD4 T-cell cytokine production in mice administered native versus polymerized ovalbumin: directed induction of T-helper type-1-like activation.
    Gieni RS; Yang X; Kelso A; Hayglass KT
    Immunology; 1996 Jan; 87(1):119-26. PubMed ID: 8666423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Destructive proteolysis by cysteine proteases in antigen presentation of ovalbumin.
    Rodriguez GM; Diment S
    Eur J Immunol; 1995 Jul; 25(7):1823-7. PubMed ID: 7621859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cathepsin S reduces allogeneic T cell priming but not graft-versus-host disease against minor histocompatibility antigens.
    Fujii H; Ivison SM; Shimizu H; Kajiwara R; Kariminia A; Yan M; Dutz JP; Schultz KR
    Biol Blood Marrow Transplant; 2012 Apr; 18(4):546-56. PubMed ID: 22178962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with cathepsin L inhibitor potentiates Th2-type immune response in Leishmania major-infected BALB/c mice.
    Zhang T; Maekawa Y; Sakai T; Nakano Y; Ishii K; Hisaeda H; Dainichi T; Asao T; Katunuma N; Himeno K
    Int Immunol; 2001 Aug; 13(8):975-82. PubMed ID: 11470767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer cell depletion fails to influence initial CD4 T cell commitment in vivo in exogenous antigen-stimulated cytokine and antibody responses.
    Wang M; Ellison CA; Gartner JG; HayGlass KT
    J Immunol; 1998 Feb; 160(3):1098-105. PubMed ID: 9570522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production.
    McMenamin C; Holt PG
    J Exp Med; 1993 Sep; 178(3):889-99. PubMed ID: 8102390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The endo/lysosomal protease cathepsin B is able to process conalbumin fragments for presentation to T cells.
    Gradehandt G; Ruede E
    Immunology; 1991 Nov; 74(3):393-8. PubMed ID: 1769688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysosomal cysteine and aspartic proteases are heterogeneously expressed and act redundantly to initiate human invariant chain degradation.
    Costantino CM; Hang HC; Kent SC; Hafler DA; Ploegh HL
    J Immunol; 2008 Mar; 180(5):2876-85. PubMed ID: 18292509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participation of cathepsin B in processing of antigen presentation to MHC class II.
    Matsunaga Y; Saibara T; Kido H; Katunuma N
    FEBS Lett; 1993 Jun; 324(3):325-30. PubMed ID: 8405375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.